Evidence map›Paper›PMID 18214172›Full record

ArticleEmerging infectious diseases2007

Ongoing genome reduction in Mycobacterium ulcerans.

Simona Rondini, Michael Käser, Timothy Stinear, Michel Tessier, Cyrill Mangold, Gregor Dernick, Martin Naegeli, Françoise Portaels, Ulrich Certa, Gerd Pluschke

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. ProfilingFuture science OA · 2023
    Review
  3. Article
  4. Genome Reduction for Niche Association inFrontiers in cellular and infection microbiology · 2017
    Article
  5. Article
  6. Review
  7. Genotyping Tools forMycobacterial diseases : tuberculosis & leprosy · 2014
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Simona RondiniSwiss Tropical Institute, Basel, Switzerland.
Michael Käser
Timothy Stinear
Michel Tessier
Cyrill Mangold
Gregor Dernick
Martin Naegeli
Françoise Portaels
Ulrich Certa
Gerd Pluschke

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Elucidation of the transmission, epidemiology, and evolution of Mycobacterium ulcerans, the causative agent of Buruli ulcer, is hampered by the striking lack of genetic diversity of this emerging pathogen. However, by using a prototype plasmid-based microarray that covered 10% of the genome, we found multiple genomic DNA deletions among 30 M. ulcerans clinical isolates of diverse geographic origins. Many of the changes appear to have been mediated by insertion sequence (IS) elements IS2404 and IS2606, which have high copy numbers. Classification of the deleted genes according to their biological functions supports the hypothesis that M. ulcerans has recently evolved from the generalist environmental M. marinum to become a niche-adapted specialist. The substantial genomic diversity, along with a prototype microarray that covered a small portion of the genome, suggests that a genome-wide microarray will make available a genetic fingerprinting method with the high resolution required for microepidemiologic studies.

Indexed as

Adaptation, PhysiologicalGenome, BacterialBuruli UlcerChromosomes, BacterialDNA Transposable ElementsEvolution, MolecularGenetic VariationHumansMolecular Sequence DataMycobacterium marinumMycobacterium ulceransOligonucleotide Array Sequence AnalysisSpecies SpecificityVirulenceDNA Transposable Elements

Identifiers

PMID18214172
PMCPMC2878211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.